SEC Form 4 · accession 0000899243-15-000174
Aeon Global Health Corp. · AGHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J David Luce
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2015 | A | 78,854 | $0.19 | A | 344,163 | D | |
| Common StockF2 | holding | — | — | — | 753,105 | I | By affiliated entity | |
| Common StockF3,F2 | holding | — | — | — | 17,487 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents issuance in lieu of cash director fees pursuant to the Company's 2011 Omnibus Equity Incentive Plan.
- F2Includes 55,951 shares of common stock issuable in lieu of cash dividends on shares of Series D preferred stock held by an entity affiliated with the reporting person. Such shares were accrued and are payable as of June 30, 2015. Reporting person believes that this transaction is exempt under Rule16a-9 under the Securities Exchange Act of 1934, as amended.
- F3Includes 4,567 shares of common stock issuable in lieu of cash dividends on shares of Series D preferred stock held by the spouse of the reporting person. Such shares were accrued and are payable as of June 30, 2015. Reporting person believes that this transaction is exempt under Rule16a-9 under the Securities Exchange Act of 1934, as amended.